Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI), a specialty pharmaceutical company, is focusing their efforts on addressing cancer and other unmet medical needs. With headquarters in Irvine, California, the company employs approximately 65 employees that meticulously strive to bring new drugs through clinical development and regulatory approval. Spectrum’s staff is devoted to promoting excellence and aims to make a difference every day. For further information, visit the Company’s web site at www.spectrumpharm.com.
- 17 years ago
QualityStocks
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Gloo Holdings, Inc. (NASDAQ: GLOO) Prices $72.8 Million IPO
Gloo (NASDAQ: GLOO) , a technology platform serving the faith and flourishing ecosystem, priced its…
-
QualityStocksNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Positioned for Growth as War Department Launches Billion-Dollar Push for U.S. Drone Dominance
Safe Pro Group (NASDAQ: SPAI), a mission-driven provider of AI-powered defense and security solutions, is…
-
QualityStocksNewsBreaks – Decent Holding Inc. (NASDAQ: DXST) Closes $8 Million Registered Offering of Class A Shares and Warrants
Decent Holding (NASDAQ: DXST), an established wastewater treatment services provider in China, closed its $8…